| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-58 |
Sentence |
denotes |
A novel electrophoretic variant of human apolipoprotein E. |
| TextSentencer_T2 |
59-116 |
Sentence |
denotes |
Identification and characterization of apolipoprotein E1. |
| TextSentencer_T3 |
117-229 |
Sentence |
denotes |
A new apolipoprotein E (apo E) phenotype has been demonstrated in a Finnish hypertriglyceridemic subject (R.M.). |
| TextSentencer_T4 |
230-346 |
Sentence |
denotes |
At the time of this study, R.M.'s plasma triglyceride and cholesterol levels were 1,021 and 230 mg/dl, respectively. |
| TextSentencer_T5 |
347-490 |
Sentence |
denotes |
The subject's apo E isoelectric focusing pattern was characterized by two major bands, one in the E3 position and the other in the E1 position. |
| TextSentencer_T6 |
491-575 |
Sentence |
denotes |
Normally the E1 position is occupied by sialylated derivatives of apo E4, E3, or E2. |
| TextSentencer_T7 |
576-694 |
Sentence |
denotes |
The E1 band of subject R.M. is not a sialylated form, however, because it was not affected by neuraminidase digestion. |
| TextSentencer_T8 |
695-921 |
Sentence |
denotes |
The identity of the E1 variant as a genetically determined structure was established by amino acid and partial sequence analyses, confirming that the variant is an example of a previously uncharacterized apo E phenotype, E3/1. |
| TextSentencer_T9 |
922-1046 |
Sentence |
denotes |
Both cysteamine modification and amino acid analysis demonstrated that this variant contains two cysteine residues per mole. |
| TextSentencer_T10 |
1047-1260 |
Sentence |
denotes |
Sequence analysis of two cyanogen bromide fragments and one tryptic fragment of the apo E3/1 showed that it differs from E2(Arg158----Cys) at residue 127, where an aspartic acid residue is substituted for glycine. |
| TextSentencer_T11 |
1261-1434 |
Sentence |
denotes |
This single amino acid interchange is sufficient to account for the one-charge difference observed on isoelectric focusing gels between E2(Arg158----Cys) and the E1 variant. |
| TextSentencer_T12 |
1435-1501 |
Sentence |
denotes |
The variant has been designated E1 (Gly127----Asp, Arg158----Cys). |
| TextSentencer_T13 |
1502-1715 |
Sentence |
denotes |
When compared with apo E3, the E1 variant demonstrated reduced ability to compete with 125I-LDL for binding to LDL (apo B,E) receptors on cultured fibroblasts (approximately 4% of the amount of binding of apo E3). |
| TextSentencer_T14 |
1716-1780 |
Sentence |
denotes |
This defective binding is similar to that of E2-(Arg158----Cys). |
| TextSentencer_T15 |
1781-1927 |
Sentence |
denotes |
Therefore, the binding defect of the variant is probably due to the presence of cysteine at residue 158, rather than aspartic acid at residue 127. |
| TextSentencer_T16 |
1928-2058 |
Sentence |
denotes |
In contrast, the apo E3 isoform from this subject demonstrated normal binding activity, indicating that it has a normal structure. |
| TextSentencer_T17 |
2059-2147 |
Sentence |
denotes |
In family studies, the vertical transmission of the apo E1 variant has been established. |
| TextSentencer_T18 |
2148-2310 |
Sentence |
denotes |
It is not yet clear, however, if the hypertriglyceridemia observed in the proband is associated with the presence of the E1(Gly127----Asp, Arg158----Cys) variant. |
| T1 |
0-58 |
Sentence |
denotes |
A novel electrophoretic variant of human apolipoprotein E. |
| T2 |
59-116 |
Sentence |
denotes |
Identification and characterization of apolipoprotein E1. |
| T3 |
117-229 |
Sentence |
denotes |
A new apolipoprotein E (apo E) phenotype has been demonstrated in a Finnish hypertriglyceridemic subject (R.M.). |
| T4 |
230-346 |
Sentence |
denotes |
At the time of this study, R.M.'s plasma triglyceride and cholesterol levels were 1,021 and 230 mg/dl, respectively. |
| T5 |
347-490 |
Sentence |
denotes |
The subject's apo E isoelectric focusing pattern was characterized by two major bands, one in the E3 position and the other in the E1 position. |
| T6 |
491-575 |
Sentence |
denotes |
Normally the E1 position is occupied by sialylated derivatives of apo E4, E3, or E2. |
| T7 |
576-694 |
Sentence |
denotes |
The E1 band of subject R.M. is not a sialylated form, however, because it was not affected by neuraminidase digestion. |
| T8 |
695-921 |
Sentence |
denotes |
The identity of the E1 variant as a genetically determined structure was established by amino acid and partial sequence analyses, confirming that the variant is an example of a previously uncharacterized apo E phenotype, E3/1. |
| T9 |
922-1046 |
Sentence |
denotes |
Both cysteamine modification and amino acid analysis demonstrated that this variant contains two cysteine residues per mole. |
| T10 |
1047-1260 |
Sentence |
denotes |
Sequence analysis of two cyanogen bromide fragments and one tryptic fragment of the apo E3/1 showed that it differs from E2(Arg158----Cys) at residue 127, where an aspartic acid residue is substituted for glycine. |
| T11 |
1261-1434 |
Sentence |
denotes |
This single amino acid interchange is sufficient to account for the one-charge difference observed on isoelectric focusing gels between E2(Arg158----Cys) and the E1 variant. |
| T12 |
1435-1501 |
Sentence |
denotes |
The variant has been designated E1 (Gly127----Asp, Arg158----Cys). |
| T13 |
1502-1715 |
Sentence |
denotes |
When compared with apo E3, the E1 variant demonstrated reduced ability to compete with 125I-LDL for binding to LDL (apo B,E) receptors on cultured fibroblasts (approximately 4% of the amount of binding of apo E3). |
| T14 |
1716-1780 |
Sentence |
denotes |
This defective binding is similar to that of E2-(Arg158----Cys). |
| T15 |
1781-1927 |
Sentence |
denotes |
Therefore, the binding defect of the variant is probably due to the presence of cysteine at residue 158, rather than aspartic acid at residue 127. |
| T16 |
1928-2058 |
Sentence |
denotes |
In contrast, the apo E3 isoform from this subject demonstrated normal binding activity, indicating that it has a normal structure. |
| T17 |
2059-2147 |
Sentence |
denotes |
In family studies, the vertical transmission of the apo E1 variant has been established. |
| T18 |
2148-2310 |
Sentence |
denotes |
It is not yet clear, however, if the hypertriglyceridemia observed in the proband is associated with the presence of the E1(Gly127----Asp, Arg158----Cys) variant. |